Skip to main content


Page 6 of 63

  1. To investigate the potential role of a novel spatially fractionated radiation therapy (SFRT) method where heterogeneous dose patterns are created in target areas with virtual rods, straight or curving, of vari...

    Authors: Luca Cozzi, Sushil Beriwal, Esa Kuusela, Supriya Chopra, Hester Burger, Nanette Joubert, Antonella Fogliata, Jai Prakash Agarwal and Pat Kupelian
    Citation: Radiation Oncology 2021 16:110
  2. The present study aimed to propose a new foetal shielding device for pregnant cancer patients to reduce the foetal dose associated with treatment techniques using multiple gantry angles, such as intensity-modu...

    Authors: Seonghee Kang, Kyeong-Hyeon Kim, Sang-Won Kang, Dong-Seok Shin, Seungwan Lee and Jin-Beom Chung
    Citation: Radiation Oncology 2021 16:109
  3. The purpose of this study is to develop a clinical application program that automatically calculates the effect for secondary cancer risk (SCR) of individual patient. The program was designed based on accurate...

    Authors: Dong-Jin Kang, Young-Joo Shin, Seonghoon Jeong, Jae-Yong Jung, Hakjae Lee and Boram Lee
    Citation: Radiation Oncology 2021 16:108
  4. The efficacy of a hydrogel spacer in stereotactic body radiotherapy (SBRT) has not been clarified. We evaluated the safety and efficacy of SBRT in combination with a hydrogel spacer for prostate cancer.

    Authors: Mami Ogita, Hideomi Yamashita, Yuki Nozawa, Sho Ozaki, Subaru Sawayanagi, Takeshi Ohta and Keiichi Nakagawa
    Citation: Radiation Oncology 2021 16:107
  5. The purpose of this study is to evaluate inter- and intra-fraction organ motion as well as to quantify clinical target volume (CTV) to planning target volume (PTV) margins to be adopted in the stereotactic tre...

    Authors: Annarita Perillo, Valeria Landoni, Alessia Farneti and Giuseppe Sanguineti
    Citation: Radiation Oncology 2021 16:106
  6. To examine treatment patterns, oncological outcomes and toxicity rates in elderly patients receiving radiotherapy for cutaneous squamous cell carcinoma (cSCC) of the head-and-neck region.

    Authors: Erik Haehl, Alexander Rühle, Rabea Klink, Tobias Kalckreuth, Tanja Sprave, Eleni Gkika, Constantinos Zamboglou, Frank Meiß, Anca-Ligia Grosu and Nils H. Nicolay
    Citation: Radiation Oncology 2021 16:105
  7. The recent implementation of MR-Linacs has highlighted theranostic opportunities of contrast agents in both imaging and radiotherapy. There is a lack of data exploring the potential of superparamagnetic iron o...

    Authors: Emily Russell, Victoria Dunne, Ben Russell, Hibaaq Mohamud, Mihaela Ghita, Stephen J. McMahon, Karl T. Butterworth, Giuseppe Schettino, Conor K. McGarry and Kevin M. Prise
    Citation: Radiation Oncology 2021 16:104
  8. The main objective of this study was to evaluate the cumulative incidence of cause-specific mortality and other causes of mortality for patients with olfactory neuroblastoma (ONB). The secondary aim was to mod...

    Authors: Lipin Liu, Qiuzi Zhong, Ting Zhao, Dazhi Chen, Yonggang Xu and Gaofeng Li
    Citation: Radiation Oncology 2021 16:103
  9. To investigate the interobserver variability (IOV) in target volume delineation of definitive radiotherapy for thoracic esophageal cancer (TEC) among cancer centers in China, and ultimately improve contouring ...

    Authors: Xiao Chang, Wei Deng, Xin Wang, Zongmei Zhou, Jun Yang, Wenling Guo, Miaoling Liu, Xiaolu Qi, Ling Li, Kaixian Zhang, Min Zhang, Yonggang Shi, Ke Liu, Yidian Zhao, Huitao Wang, Zhilong Yu…
    Citation: Radiation Oncology 2021 16:102
  10. We recently described the validation of deep learning-based auto-segmented contour (DC) models for organs at risk (OAR) and clinical target volumes (CTV). In this study, we evaluate the performance of implemen...

    Authors: Jordan Wong, Vicky Huang, Derek Wells, Joshua Giambattista, Jonathan Giambattista, Carter Kolbeck, Karl Otto, Elantholi P. Saibishkumar and Abraham Alexander
    Citation: Radiation Oncology 2021 16:101
  11. Local recurrence (LR) is clinical challenge in the treatment of esophageal squamous cell carcinoma (ESCC). The current study aimed to determine the optimal re-irradiation dose for local recurrent esophageal sq...

    Authors: Xun Wu, Xingsheng Hu, Junru Chen and Lang He
    Citation: Radiation Oncology 2021 16:100
  12. Centrally located lung tumors present treatment challenges given their proximity to mediastinal structures including the central airway, esophagus, major vessels, and heart. Therapeutic options can be limited ...

    Authors: Stephanie M. Yoon, Robert Suh, Fereidoun Abtin, Drew Moghanaki, Scott Genshaft, Mitchell Kamrava, Alexandra Drakaki, Sandy Liu, Puja Venkat, Alan Lee and Albert J. Chang
    Citation: Radiation Oncology 2021 16:99
  13. Brachial plexopathy is a potentially serious complication from stereotactic body radiation therapy (SBRT) that has not been widely studied. Therefore, we compared datasets from two different institutions and g...

    Authors: Irina Kapitanova, Sharmi Biswas, Sabrina Divekar, Eric J. Kemmerer, Robert A. Rostock, Kenneth M. Forster, Rachel J. Grimm, Carla J. Scofield, Jimm Grimm, Bahman Emami and Anand Mahadevan
    Citation: Radiation Oncology 2021 16:98
  14. In this study, we performed a consecutive macropathologic analysis to assess microscopic extension (ME) in high-grade glioma (HGG) to determine appropriate clinical target volume (CTV) margins for radiotherapy.

    Authors: Shulun Nie, Yufang Zhu, Jia Yang, Tao Xin, Song Xue, Xianbin Zhang, Jujie Sun, Dianbin Mu, Yongsheng Gao, Zhaoqiu Chen, Xingchen Ding, Jinming Yu and Man Hu
    Citation: Radiation Oncology 2021 16:97
  15. We investigated the geometric and dosimetric impact of three-dimensional (3D) generative adversarial network (GAN)-based metal artifact reduction (MAR) algorithms on volumetric-modulated arc therapy (VMAT) and...

    Authors: Mitsuhiro Nakamura, Megumi Nakao, Keiho Imanishi, Hideaki Hirashima and Yusuke Tsuruta
    Citation: Radiation Oncology 2021 16:96
  16. We have carried out a study to determine the scope for reducing heart doses in photon beam radiotherapy of locally advanced non-small cell lung cancer (LA-NSCLC).

    Authors: Louise Turtle, Neeraj Bhalla, Andrew Willett, Robert Biggar, Jonathan Leadbetter, Georgios Georgiou, James M. Wilson, Sindu Vivekanandan, Maria A. Hawkins, Michael Brada and John D. Fenwick
    Citation: Radiation Oncology 2021 16:95
  17. This retrospective study was to assess and compare the toxicity and efficacy of concurrent chemoradiotherapy (CCRT) with S-1 or docetaxel and cisplatin in patients with locally advanced esophageal squamous cel...

    Authors: Xi-Lei Zhou, Chang-Hua Yu, Wan-Wei Wang, Fu-Zhi Ji, Yao-Zu Xiong, Wei-Guo Zhu and Yu-Suo Tong
    Citation: Radiation Oncology 2021 16:94
  18. Patients with locally advanced sigmoid colon cancer (LASCC) have limited treatment options and a dismal prognosis with poor quality of life. This retrospective study aimed to further evaluate the feasibility...

    Authors: Shao-Qing Niu, Rong-Zhen Li, Yan Yuan, Wei-Hao Xie, Qiao-Xuan Wang, Hui Chang, Zhen-Hai Lu, Pei-Rong Ding, Li-Ren Li, Xiao-Jun Wu, Zhi-Fan Zeng, Wei-Wei Xiao and Yuan-Hong Gao
    Citation: Radiation Oncology 2021 16:93
  19. Lymph node metastases presenting with locally advanced cervical cancer are poor prognostic features. Modern radiotherapy approaches enable dose escalation to radiologically abnormal nodes. This study reports ...

    Authors: Iresha Jayatilakebanda, Yat Man Tsang and Peter Hoskin
    Citation: Radiation Oncology 2021 16:92

    The Correction to this article has been published in Radiation Oncology 2021 16:156

  20. The application of delayed-enhancement magnetic resonance (DE-MR) simulation imaging in lumpectomy cavity (LC) delineation for prone radiotherapy in patients with an invisible seroma or a low seroma clarity sc...

    Authors: Changhui Zhao, Jianbin Li, Wei Wang, Guanzhong Gong, Liang Xu, Yingjie Zhang, Fengxiang Li, Qian Shao, Jinzhi Wang, Xijun Liu and Min Xu
    Citation: Radiation Oncology 2021 16:91
  21. Early stage Merkel cell carcinoma (MCC) is a rare and aggressive primary skin cancer. The standard of care for MCC is broad excision and adjuvant external beam radiation therapy (EBRT). However, for some patie...

    Authors: Manon Dubois, Henry Abi Rached, Alexandre Escande, Frédéric Dezoteux, Franck Darloy, Anaïs Jouin, Maeva Kyheng, Julien Labreuche, Véronique Dziwniel, Xavier Mirabel and Laurent Mortier
    Citation: Radiation Oncology 2021 16:90
  22. Studying the clinical utility of deep-inspirational breath-hold (DIBH) in left breast cancer radiotherapy (RT) was aimed at focusing on dosimetry and feasibility aspects.

    Authors: Szilvia Gaál, Zsuzsanna Kahán, Viktor Paczona, Renáta Kószó, Rita Drencsényi, Judit Szabó, Ramóna Rónai, Tímea Antal, Bence Deák and Zoltán Varga
    Citation: Radiation Oncology 2021 16:89
  23. Hypofractionated post-prostatectomy radiotherapy is emerging practice, however with no randomized evidence so far to support it’s use. Additionally, patients with persistent PSA after prostatectomy may have ag...

    Authors: Jure Murgic, Blanka Jaksic, Marin Prpic, Davor Kust, Amit Bahl, Mirjana Budanec, Angela Prgomet Secan, Pierfrancesco Franco, Ivan Kruljac, Borislav Spajic, Nenad Babic, Bozo Kruslin, Mario Zovak, Eduardo Zubizarreta, Eduardo Rosenblatt and Ana Fröbe
    Citation: Radiation Oncology 2021 16:88
  24. The Polaris product line from Northern Digital Inc. is well known for accurate optical tracking measurements in research and medical environments. The Spectra position sensor, to date often found in image guid...

    Authors: Giovanni Fattori, Antony John Lomax, Damien Charles Weber and Sairos Safai
    Citation: Radiation Oncology 2021 16:87
  25. In unresectable hepatocellular carcinoma several local ablative treatments are available. Among others, radiation based treatments such as stereotactic body radiotherapy (SBRT) and high-dose rate interstitial ...

    Authors: Franziska Walter, Lukas Nierer, Maya Rottler, Anna Sophie Duque, Helmut Weingandt, Justus Well, Roel Shpani, Guillaume Landry, Max Seidensticker, Florian Streitparth, Jens Ricke, Claus Belka and Stefanie Corradini
    Citation: Radiation Oncology 2021 16:86
  26. the aim of this study is to perform an external validation for the Candiolo nomogram, a predictive algorithm of biochemical and clinical recurrences in prostate cancer patients treated by radical Radiotherapy,...

    Authors: Domenico Gabriele, Alessia Guarneri, Sara Bartoncini, Fernando Munoz, Matteo Tamponi, Filippo Russo, Georgios Stamatakos, Caterina Guiot, Daniele Regge and Umberto Ricardi
    Citation: Radiation Oncology 2021 16:85
  27. To assess the effects of daily adaptive MR-guided replanning in stereotactic body radiation therapy (SBRT) of liver metastases based on a patient individual longitudinal dosimetric analysis.

    Authors: Michael Mayinger, Roman Ludwig, Sebastian M. Christ, Riccardo Dal Bello, Alex Ryu, Nienke Weitkamp, Matea Pavic, Helena Garcia Schüler, Lotte Wilke, Matthias Guckenberger, Jan Unkelbach, Stephanie Tanadini-Lang and Nicolaus Andratschke
    Citation: Radiation Oncology 2021 16:84
  28. This communication reports the identification of a new panel of transcriptional changes in inflammation-associated genes observed in response to ionising radiation received by radiotherapy patients.

    Authors: Lourdes Cruz-Garcia, Christophe Badie, Selvakumar Anbalagan, Jayne Moquet, Lone Gothard, Grainne O’Brien, Navita Somaiah and Elizabeth A. Ainsbury
    Citation: Radiation Oncology 2021 16:83
  29. Positron emission tomography-(PET) has evolved as a powerful tool to guide treatment for prostate cancer (PC). The aim of this survey was to evaluate the acceptance and use of PET—especially with prostate-spec...

    Authors: Marco M. E. Vogel, Sabrina Dewes, Eva K. Sage, Michal Devecka, Jürgen E. Gschwend, Matthias Eiber, Stephanie E. Combs and Kilian Schiller
    Citation: Radiation Oncology 2021 16:82
  30. The current phase III EORTC 1420 Best-of trial (NCT02984410) compares the swallowing function after transoral surgery versus intensity modulated radiotherapy (RT) in patients with early-stage carcinoma of the ...

    Authors: J-J Stelmes, E. Vu, V. Grégoire, C. Simon, E. Clementel, J. Kazmierska, W. Grant, M. Ozsahin, M. Tomsej, L. Vieillevigne, C. Fortpied, E. C. Hurkmans, A. Branquinho, N. Andratschke, F. Zimmermann and D.-C. Weber
    Citation: Radiation Oncology 2021 16:81
  31. Radiomics is a new technology to noninvasively predict survival prognosis with quantitative features extracted from medical images. Most radiomics-based prognostic studies of non-small-cell lung cancer (NSCLC)...

    Authors: Yuto Sugai, Noriyuki Kadoya, Shohei Tanaka, Shunpei Tanabe, Mariko Umeda, Takaya Yamamoto, Kazuya Takeda, Suguru Dobashi, Haruna Ohashi, Ken Takeda and Keiichi Jingu
    Citation: Radiation Oncology 2021 16:80
  32. The optimal dose and fractionation scheme of stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) remains unclear due to different tolerated liver volumes and degrees of cirrhosis. In ...

    Authors: Ting-Shi Su, Qiu-Hua Liu, Xiao-Fei Zhu, Ping Liang, Shi-Xiong Liang, Lin Lai, Ying Zhou, Yong Huang, Tao Cheng and Le-Qun Li
    Citation: Radiation Oncology 2021 16:79
  33. To improve split-VMAT technique by optimizing treatment delivery time for deep-inspiration breath hold (DIBH) radiotherapy in left-sided breast cancer patients, when automatic beam-interruption devices are not...

    Authors: Sara Poeta, Younes Jourani, Alex De Caluwé, Robbe Van den Begin, Dirk Van Gestel and Nick Reynaert
    Citation: Radiation Oncology 2021 16:77
  34. Liver compresses are frequently used in integrative medicine as supportive therapy during cancer treatment in order to reduce fatigue. We performed a pilot study to test whether the external application of yar...

    Authors: Pirus Ghadjar, Wiebke Stritter, Irina von Mackensen, Felix Mehrhof, Clara Foucré, Vincent H. Ehrhardt, Marcus Beck, Pimrapat Gebert, Goda Kalinauskaite, Jacqueline S. Luchte, Carmen Stromberger, Volker Budach, Angelika Eggert and Georg Seifert
    Citation: Radiation Oncology 2021 16:76
  35. Despite modern treatment techniques, radiotherapy (RT) in patients with head and neck cancer (HNC) may be associated with high rates of acute and late treatment-related toxicity. The most effective approach to...

    Authors: Thomas Held, Christopher Herpel, Franz Sebastian Schwindling, Leo Christ, Kristin Lang, Sebastian Regnery, Tanja Eichkorn, Adriane Hommertgen, Cornelia Jaekel, Johannes Krisam, Julius Moratin, Jan Mrosek, Karl Metzger, Karim Zaoui, Tracy Moutsis, Semi Harrabi…
    Citation: Radiation Oncology 2021 16:75
  36. To generate and validate state-of-the-art radiomics models for prediction of radiation-induced lung injury and oncologic outcome in non-small cell lung cancer (NSCLC) patients treated with robotic stereotactic...

    Authors: Khaled Bousabarah, Oliver Blanck, Susanne Temming, Maria-Lisa Wilhelm, Mauritius Hoevels, Wolfgang W. Baus, Daniel Ruess, Veerle Visser-Vandewalle, Maximilian I. Ruge, Harald Treuer and Martin Kocher
    Citation: Radiation Oncology 2021 16:74
  37. Despite complete surgical resection brain metastases are at significant risk of local recurrence without additional radiation therapy. Traditionally, the addition of postoperative whole brain radiotherapy (WBR...

    Authors: Giuseppe Minniti, Maximilian Niyazi, Nicolaus Andratschke, Matthias Guckenberger, Joshua D. Palmer, Helen A. Shih, Simon S. Lo, Scott Soltys, Ivana Russo, Paul D. Brown and Claus Belka
    Citation: Radiation Oncology 2021 16:73

    The Letter to the Editor to this article has been published in Radiation Oncology 2021 16:127

  38. The study objective was to establish the local effect model (LEM) rectum constraints for 12-, 8-, and 4-fraction carbon-ion radiotherapy (CIRT) in patients with localized prostate carcinoma (PCA) using microdo...

    Authors: Weiwei Wang, Ping Li, Yinxiangzi Sheng, Zhijie Huang, Jingfang Zhao, Zhengshan Hong, Kambiz Shahnazi, Guo-Liang Jiang and Qing Zhang
    Citation: Radiation Oncology 2021 16:72
  39. Clinical target volume (CTV) contouring guidelines are frequently developed through studies in which experts contour the CTV for a representative set of cases for a given treatment site and the consensus CTVs ...

    Authors: Liam S. P. Lawrence, Lee C. L. Chin, Rachel W. Chan, Timothy K. Nguyen, Arjun Sahgal, Chia-Lin Tseng and Angus Z. Lau
    Citation: Radiation Oncology 2021 16:71
  40. Previous studies have found that patients with subclinical interstitial lung disease (ILD) are highly susceptible to developing radiation pneumonitis (RP) after thoracic radiation therapy. In the present study...

    Authors: Fangjuan Li, Hui Liu, Hongyu Wu, Shixiong Liang and Yaping Xu
    Citation: Radiation Oncology 2021 16:70
  41. Patients with unresectable advanced cutaneous squamous cell carcinoma (cSCC) are generally treated with palliative intent. Immune checkpoint blockade has significant activity in the palliative setting in patie...

    Authors: Charles Lin, Trishna Ballah, Michelle Nottage, Karen Hay, Benjamin Chua, Lizbeth Kenny, Paul Thomas, Michele Teng, Jacqui Keller, Trang Le, Jennifer Edmunds and Brett Hughes
    Citation: Radiation Oncology 2021 16:69
  42. Stereotactic body radiotherapy (SBRT) is a promising ablative modality for hepatocellular carcinoma (HCC) especially for those with small-sized or early-stage tumors. This study aimed to synthesize available d...

    Authors: Yanyan Long, Yan Liang, Shujie Li, Jing Guo, Ying Wang, Yan Luo and Yongzhong Wu
    Citation: Radiation Oncology 2021 16:68
  43. An amendment to this paper has been published and can be accessed via the original article.

    Authors: Jeffrey M. Ryckman, Michael Baine, Joseph Carmicheal, Ferdinand Osayande, Richard Sleightholm, Kaeli Samson, Dandan Zheng, Weining Zhen, Chi Lin and Chi Zhang
    Citation: Radiation Oncology 2021 16:67

    The original article was published in Radiation Oncology 2020 15:33

  44. Most studies on synthetic computed tomography (sCT) generation for brain rely on in-house developed methods. They often focus on performance rather than clinical feasibility. Therefore, the aim of this work wa...

    Authors: Minna Lerner, Joakim Medin, Christian Jamtheim Gustafsson, Sara Alkner, Carl Siversson and Lars E. Olsson
    Citation: Radiation Oncology 2021 16:66
  45. This work addresses a basic inconsistency in the way dose is accumulated in radiotherapy when predicting the biological effect based on the linear quadratic model (LQM). To overcome this inconsistency, we intr...

    Authors: Nina I. Niebuhr, Mona Splinter, Tilman Bostel, Joao Seco, Clemens M. Hentschke, Ralf O. Floca, Juliane Hörner-Rieber, Markus Alber, Peter Huber, Nils H. Nicolay and Asja Pfaffenberger
    Citation: Radiation Oncology 2021 16:65
  46. Definitive chemoradiotherapy (CRT) is standard of care for nasopharyngeal carcinoma. Due to the tumor localization and concomitant platinum-based chemotherapy, hearing impairment is a frequent complication, wi...

    Authors: Enkelejda Lamaj, Erwin Vu, Janita E. van Timmeren, Chiara Leonardi, Louise Marc, Izabela Pytko, Matthias Guckenberger and Panagiotis Balermpas
    Citation: Radiation Oncology 2021 16:64
  47. Radiation-induced myelopathy is a severe and irreversible complication that occurs after a long symptom-free latency time if the spinal cord was exposed to a significant irradiation dose during tumor treatment...

    Authors: Thomas Welzel, Alina L. Bendinger, Christin Glowa, Inna Babushkina, Manfred Jugold, Peter Peschke, Jürgen Debus, Christian P. Karger and Maria Saager
    Citation: Radiation Oncology 2021 16:63
  48. There is a large lack of evidence for optimal treatment in oligometastatic head and neck cancer and it is especially unclear which patients benefit from radical local treatment of all tumour sites.

    Authors: Thomas Weissmann, Daniel Höfler, Markus Hecht, Sabine Semrau, Marlen Haderlein, Irina Filimonova, Benjamin Frey, Christoph Bert, Sebastian Lettmaier, Konstantinos Mantsopoulos, Heinrich Iro, Rainer Fietkau and Florian Putz
    Citation: Radiation Oncology 2021 16:62
  49. Primary cardiac tumors are an extremely rare disease with limited prognosis. The treatment of choice is surgery. Other treatment options include chemotherapy and radiation therapy, which historically represent...

    Authors: Stefanie Corradini, Rieke von Bestenbostel, Angela Romano, Adrian Curta, Dorit Di Gioia, Lorenzo Placidi, Maximilian Niyazi and Luca Boldrini
    Citation: Radiation Oncology 2021 16:60

Annual Journal Metrics